Moderately to Severely Active Rheumatoid Arthritis
2 clinical trials · Condition
◉ Watch Moderately to Severely Active Rheumatoid Arthritis
| Record | Firm | Date |
|---|---|---|
| Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis (NCT03522415) | Shanghai Henlius Biotech | 2018-05-28 |
Track Moderately to Severely Active Rheumatoid Arthritis automatically
Every clearance here is in the API, with alerts when new ones post.